OFW
Omnia Family Wealth Portfolio holdings
AUM
$276M
1-Year Return
18.83%
This Quarter Return
+2.9%
1 Year Return
+18.83%
3 Year Return
+72.5%
5 Year Return
+91.99%
10 Year Return
–
AUM
$209M
AUM Growth
+$2.76M
(+1.3%)
Cap. Flow
-$2.69M
Cap. Flow
% of AUM
-1.29%
Top 10 Holdings %
Top 10 Hldgs %
69.26%
Holding
769
New
41
Increased
129
Reduced
82
Closed
53
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.88M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$1.22M |
| 3 |
iShares TIPS Bond ETF
TIP
|
$724K |
| 4 |
Alerian MLP ETF
AMLP
|
$598K |
| 5 |
Columbia Emerging Markets Consumer ETF
ECON
|
$473K |
Top Sells
Sector Composition
| 1 | Financials | 4.8% |
| 2 | Communication Services | 3.57% |
| 3 | Technology | 2.38% |
| 4 | Healthcare | 2.21% |
| 5 | Consumer Staples | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
American Airlines Group
AAL
$8.63B
| $10K | ﹤0.01% |
193
| – | – |
|
277
AvalonBay Communities
AVB
$27.8B
| $10K | ﹤0.01% |
51
| – | – |
|
278
Estee Lauder
EL
$32.1B
| $10K | ﹤0.01% |
109
+1
| +0.9% | +$92 |
|
279
Entergy
ETR
$39.2B
| $10K | ﹤0.01% |
256
+150
| +142% | +$5.86K |
|
280
Marsh & McLennan
MMC
$100B
| $10K | ﹤0.01% |
123
+49
| +66% | +$3.98K |
|
281
M&T Bank
MTB
$31.2B
| $10K | ﹤0.01% |
+61
| New | +$10K |
|
282
Northern Trust
NTRS
$24.3B
| $10K | ﹤0.01% |
106
| – | – |
|
283
Omeros
OMER
$284M
| $10K | ﹤0.01% |
+500
| New | +$10K |
|
284
Regeneron Pharmaceuticals
REGN
$60.8B
| $10K | ﹤0.01% |
21
+14
| +200% | +$6.67K |
|
285
Rio Tinto
RIO
$104B
| $10K | ﹤0.01% |
238
+7
| +3% | +$294 |
|
286
Simon Property Group
SPG
$59.5B
| $10K | ﹤0.01% |
+61
| New | +$10K |
|
287
Toyota
TM
$260B
| $10K | ﹤0.01% |
92
+1
| +1% | +$109 |
|
288
Vanguard FTSE Pacific ETF
VPL
$7.79B
| $10K | ﹤0.01% |
154
| – | – |
|
|
UBA
289
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $10K | ﹤0.01% |
500
| – | – |
|
290
United Airlines
UAL
$34.5B
| $10K | ﹤0.01% |
128
| – | – |
|
291
Thermo Fisher Scientific
TMO
$186B
| $10K | ﹤0.01% |
58
+18
| +45% | +$3.1K |
|
292
Adobe
ADBE
$148B
| $9K | ﹤0.01% |
66
| – | – |
|
293
Chemours
CC
$2.34B
| $9K | ﹤0.01% |
240
| – | – |
|
294
Crown Castle
CCI
$41.9B
| $9K | ﹤0.01% |
87
+58
| +200% | +$6K |
|
295
Cleveland-Cliffs
CLF
$5.63B
| $9K | ﹤0.01% |
1,250
| – | – |
|
296
Salesforce
CRM
$239B
| $9K | ﹤0.01% |
100
| – | – |
|
297
Quest Diagnostics
DGX
$20.5B
| $9K | ﹤0.01% |
82
| – | – |
|
298
Eaton
ETN
$136B
| $9K | ﹤0.01% |
113
-1,546
| -93% | -$123K |
|
299
Gilead Sciences
GILD
$143B
| $9K | ﹤0.01% |
127
-266
| -68% | -$18.9K |
|
300
GSK
GSK
$81.6B
| $9K | ﹤0.01% |
+170
| New | +$9K |
|